Michael Schaefer

11PUBLICATIONS
27CO-AUTHORS
Characterisation of biological macromoleculesBiomedical imagingAutonomic nervous systemCheminformatics and quantitative structure-activity relationshipsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 31, 2026
Defining AV2-1 as a novel pharmacological probe to target human and rodent TRPV2.

Andrea Leipe, Julia A Rocereta, Ruth A Pumroy

|Jan 16, 2026
Ideal efficacy photoswitching for chromocontrol of TRPC4/5 channel functions in live tissues.

Markus Müller, Konstantin Niemeyer, Navin K Ojha

|Aug 20, 2025
Nitroxoline is a novel inhibitor of NLRP3-dependent pyroptosis.

Christina Maeder, Roberto Baumann, Susanne Gaul

|Dec 06, 2024
Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity.

Hannah Lentschat, Fabian Liessmann, Claiborne Tydings

|May 31, 2023
Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide-induced migration of primary macrophages.

Rick Raudszus, Andrea Paulig, Nicole Urban

|Aug 02, 2022
KS0365, a novel activator of the transient receptor potential vanilloid 3 (TRPV3) channel, accelerates keratinocyte migration.

Marion Maier, Stefan Olthoff, Kerstin Hill

Pageof 2

Frequent Collaborators

4 joint publications

Kerstin Hill

2 joint publications

Alexander Kogel

2 joint publications

Nicole Urban

1 joint publications

Stephanie Häfner